Maitreya Medicare Limited
MAITREYA (NSE) · ISIN INE0PLQ01011 · Hospital · listed 2023
In Q2 FY25 (quarter to 30 September 2024, standalone), revenue was ₹22.18 cr and profit after tax ₹1.35 cr.
Open the full company file Every section, filings and your notes, in the app.
Quarterly results
| Quarter | Revenue | Profit after tax | EPS (₹) | Filed |
|---|---|---|---|---|
| Q2 FY25 standalone | ₹22.18 cr | ₹1.35 cr | 1.99 | 28 Oct 2024 |
Balance sheet
| As of | Total equity | Borrowings | Total assets |
|---|---|---|---|
| 30 Sep 2026 standalone | ₹31.64 cr | ₹22.41 cr | ₹64.39 cr |
| 31 Mar 2026 standalone | ₹30.21 cr | ₹22.88 cr | ₹63.29 cr |
| 30 Sep 2025 standalone | ₹31.68 cr | ₹2.71 cr | ₹45.65 cr |
Shareholding
| Promoter | FII | DII | Public |
|---|---|---|---|
| 73.11% | 0.00% | 0.00% | 26.89% |
Latest filings
- Maitreya Medicare Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 22 October 2026 · NSE
- Annual Report FY2025-26 (New) 24 August 2026 · NSE
- Maitreya Medicare Limited has informed the Exchange regarding Outcome of Board Meeting held on August 24, 2026. 24 August 2026 · NSE
- Maitreya Medicare Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regu 28 July 2026 · NSE
- Maitreya Medicare Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regu 17 June 2026 · NSE
Other companies in Hospital
- Apollo Hospitals Enterprise Limited
- Narayana Hrudayalaya Ltd.
- Global Health Limited
- Max Healthcare Institute Limited
- Aster DM Quality Care Limited
- Fortis Healthcare Limited
- Krishna Institute of Medical Sciences Limited
- Rainbow Childrens Medicare Limited
Figures as filed by the company with NSE and BSE; surveillance status from the exchanges' lists. Updated 29 October 2026.
Information and calculation tools by Rachid Asen. Not investment advice or research. Facts from company filings and the exchanges' lists, for information only; not a recommendation to buy, sell or hold. Verify with the exchange.